1Hjertaker BT. Froystein T, Schem BC. A thermometry system for quality assurance and documentation of whole body hyperthermia procedures. Int J Hyperthermia, 2005, 21 : 45-55.
2Westermann AM, Wiedemann GJ, Jager E, et al. A Systemic Hyperthermia Oncologic Working Group trial: ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology, 2003, 64:312-321.
3Douwes F, Bogovic J, Douwes O, et al. Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer. Int J Clin Oncol, 2004, 9: 85-91.
4Bakhshandeh A, Bruns I, Traynor A, et al, Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole hody hyperthermia for malignant pleural mesothelioma. Lung Cancer, 2003, 39 : 339-345,
5Kido Y, Kuwano H, Maehara Y, et al. Increased cytotoxicity of lowdose, long-duration exposure to 5-fluorouraeil of V-79 cells with hyperthermia. Cancer Chemother Pharmaeol, 1991,28: 251-254.
6Katschinski DM, Wiedemann G J, Mentzel M, et al. Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia. Cancer Lett, 1997, 115: 195-199.
